Tatyana Goncharova

Prof. Dr. Tatyana Goncharova

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in The Journal of Toxicological Sciences
Verified
Journal Article
Closed access
PDF file
NKNaoki KUNUGITA
Naoki KUNUGITA
NMNan Mei
Nan Mei
TGTatyana Goncharova
Tatyana Goncharova
TNToshiyuki Norimura
Toshiyuki Norimura
It is well known that somatic mutations are induced by ionizing irradiation. We have previously reported the measurement of mutant frequency (MF) on the T-cell receptor (TCR) gene in mouse T-lymphocytes after irradiation by flow cytomery. In this study, we developed an in vitro system using murine EL-4 lymphoma cells and observed frequency of cells defective in TCR gene expression after exposure to ionizing irradiation. EL-4 cells were stained with fluorescein-labeled anti-CD4 and phycoerythrin-labeled anti-CD3 antibodies. They were analyzed with a flow cytometer to detect mutant EL-4 cells lacking surface expression of TCR/CD3 complexes which showed CD3−, CD4+ due to a somatic mutation at the TCR genes. Mutant cells could be observed at 2 days after 3 Gy irradiation. MF of EL-4 cells was 6.7 × 10−4 for 0 Gy and the value increased to the maximum level of 39 × 10 −4 between 4 and 8 days after 3 Gy irradiation and these data were found to be best fitted by a linear-quadratic dose-response model. After the peak value the TCR MF gradually decreased with a half-life of approximately 3.2 days. We also examined the hprt mutant frequencies at seven days after irradiation and the cytokinesis-blocked micronucleus frequency at 20 hrs after irradiation. The frequencies of hprt mutation and micronuclei were found to be best fitted by a linear-quadratic dose-response model and a linear dose-response model, respectively. The method to detect mutation on TCR gene is quick and easy in comparison with other methods and is considered useful for the mutagenicity test.

3 December 2024 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
NON. A. Omarbayeva
N. A. Omarbayeva
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
DOD. Kh. Omarov
D. Kh. Omarov
AAA. Askandirova
A. Askandirova
KKKh. Keskin
Kh. Keskin
AJA. K. Jakipbayeva
A. K. Jakipbayeva
Background. Oncologists notice an increasing prevalence of female reproductive system pathological conditions that lead to benign and malignant diseases of mammary glands. Fibrocystic breast diseases (FBD) occur in approximately 80 % of women of reproductive age worldwide. Currently, there is no single widely accepted treatment for FBD. The therapy mainly includes surgery and hormonal treatment. A few herbal medicines effective against FBD include Vitex agnus-castus (VAC) medications. According to many studies, the absence of timely targeted preventive therapy puts patients with FBD at risk of developing malignant tumors. FBD is a risk factor for cancer development and turns into cancer in 3–6 % of patients.Aim. To assess the effectiveness of VAC against FBD.Materials and methods. In this study, 150 women aged 40+ with FBD were randomly assigned to the treatment group (n = 78) or the controls (n = 72). The groups were similar in demographic characteristics, including age, parity, menopause, history of abortions, family history of breast cancer, and alcohol and tobacco consumption. The treatment group received two tablets of VAC extract (each containing 162 mg) daily for six months. At baseline, weeks 12 and 24, all participants were evaluated using a visual analog scale and ultrasound examination.Results. Breast pain decreased significantly in the treatment group, and the median visual analog scale scores at weeks 12 and 24 decreased significantly compared to baseline in the treatment group (89.7 % at baseline, 76.9 % at week 12, and 42.3 % at week 24) compared to the controls (66.3 % at baseline, 63.9 % at week 12 and 61.1 % at week 24). Furthermore, the breast ultrasound findings at weeks 12 and 24 revealed that regression rates in the treatment group were significantly higher than in the control arm (46.2 % vs. 6.9 % at week 12; 55.1 % vs. 8.3 % at week 24).Conclusion. VAC is effective in managing patients with FBD. VAC treatment efficacy can be evaluated using a visual analog scale and ultrasound examination. The herbal remedy VAC extract used in this treatment for patients with FBD has proven effective in preventing breast cancer.

15 May 2023 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
TGTatyana Goncharova
Tatyana Goncharova
NON. A. Omarbayeva
N. A. Omarbayeva
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
MOM. G. Orazgaliyeva
M. G. Orazgaliyeva
LML. A. Malysheva
L. A. Malysheva
Introduction. The growth of primary breast tumor morbidity in the last ten years and increased number of patients with disseminated breast cancer in the Republic of Kazakhstan require the search for methods of early diagnosis of malignant tumors. Determination of breast cancer markers in epigenetic studies allows to use them as diagnostic signs of the presence of malignant tumor and as predictors of treatment effectiveness in patients with this pathology.Aim. To perform a search for therapeutic and prognostic breast cancer markers.Materials and methods. The study included samples of biological material (peripheral blood) of 50 deemed healthy individuals and 103 patients with locally advanced and disseminated breast cancer receiving special therapy. The following methods were used: blood collection, DNA extraction, creation of DNA methylation profiles, sequencing, statistical data analysis.Results. The results of search for epigenetic mutations in peripheral blood of patients with breast cancer showed their role as specific diagnostic, therapeutic and prognostic markers with specificity 0.91 % and sensitivity 0.94 %. The hypothesis on therapeutic significance of identified earlier diagnostic markers in patients with breast cancer, namely hypermethylation of CpG islands associated with genes JAM3, C17orf64, MSC, C7orf51 and CpG island associated with intragene part of chromosome 5 (chr5: 77,208,034–77,329,434) was tested and confirmed.Conclusion. A correlation between DNA methylation characteristics and disease progression during treatment was shown. The study results can be used in clinical practice: epigenetic markers, such as methylation in the CpG islets associated with the JAM3, C17orf64, MSC, C7orf51 genes, and in the CpG islet associated with the intragenic site of chromosome 5 (chr5: 77,208,034–77,329,434) can be used as prognostic markers and therapeutic predictors of breast cancer.

27 August 2025 in Viruses
Verified
Journal Article
Open access
PDF file
Saken KhaidarovSaken Khaidarov
Saken Khaidarov
Abdul Bari HejranAbdul Bari Hejran
Abdul Bari Hejran
AMAizhan Moldakaryzova
Aizhan Moldakaryzova
SISlu Izmailova
Slu Izmailova
BNBayan Kadirovna Nurgaliyeva
Bayan Kadirovna Nurgaliyeva
YBYerbol Burashev
Yerbol Burashev
The persistent evolution of SARS-CoV-2 necessitates novel antiviral strategies. This study evaluated the anti-HIV prodrugs tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) for repurposing against SARS-CoV-2, assessing key pharmacological indices (CC50, EC50, cytostatic effect, and therapeutic window). In vitro screening in Vero E6 cells measured cytotoxicity (via CCK-8/MTT assays) and antiviral activity against Kazakh B.1 and Wuhan strains. TDF (50 µg/mL) reduced high viral loads (MOI 2) by ~2 log10 (100% inhibition), with minimal cytotoxicity (≥75% viability). TAF achieved near-complete suppression (100% inhibition) at 50 µg/mL, exhibiting dose-dependent inhibition (68–100%) at lower viral loads (MOI 0.01). Both prodrugs showed enhanced antiviral activity with prolonged exposure (96 h). Synergy assessments demonstrated favourable combination indices (CI < 1). Electron microscopy confirmed virion integrity post-treatment. These findings highlight TDF and TAF as promising candidates against SARS-CoV-2, with particular potential for targeting lymphoid reservoirs—sites implicated in persistent viral reservoirs that may contribute to long COVID pathogenesis. Further clinical validation is warranted.

10 October 2023 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
NON. Omarbayeva
N. Omarbayeva
DOD. Omarov
D. Omarov
AAA. Abdrakhmanova
A. Abdrakhmanova
KSK. Smagulova
K. Smagulova
TGTatyana Goncharova
Tatyana Goncharova
Relevance: Breast cancer (BC) is one of the major health problems in the Republic of Kazakhstan. Genome-wide association studies (GWAS) are used to identify genetic factors contributing to breast cancer development in Kazakhstan and worldwide. The GWAS method consistently helps to find associations between certain single nucleotide polymorphisms (SNPs) in the genome and the development of pathological conditions, including breast cancer, by identifying more than 170 genomic sites. In addition to searching for loci associated with BC, these studies have expanded our understanding of BC heritability using SNPs located in regulatory areas and identifying DNA variants associated with drug metabolism for treatment personalization purposes. The study aimed to highlight the key concepts of modern methods in genetics based on GWAS. Methods: A literature search in PubMed, Scopus, GWAS Catalog, Cochrane Database of Systematic Reviews, etc., was performed to select and analyze relevant information. Results: The article describes significant GWAS studies in the field of breast cancer, describes certain genes associated with the development of the disease, identifies shortcomings, and identifies further strategies for the development of GWAS in the Republic of Kazakhstan. Conclusion: The results of this study have improved our understanding of the biological mechanisms that contribute to breast cancer risk and may ultimately lead to the development of new targeted therapies for the disease.

3 December 2024 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
AAA. Zh. Abdrakhmanova
A. Zh. Abdrakhmanova
NKN. S. Khvan
N. S. Khvan
TGTatyana Goncharova
Tatyana Goncharova
SSSh. S. Sultanseitov
Sh. S. Sultanseitov
ABA. B. Bayzhigitov
A. B. Bayzhigitov
ӘҚӘ. С. Қаженова
Ә. С. Қаженова
Over 5,000 new cases of breast cancer are diagnosed in the Republic of Kazakhstan every year. More than 40 % of them are treated with organ-preserving surgery followed by radiation therapy to minimize the risk of local recurrence. Notably, over 70 % of breast cancer recurrences occur within the primary tumor bed. Radiation therapy aims to prevent recurrence after radical surgery, and precise targeting is crucial for its effectiveness. However, the lack of standardized methods for the exact localization of the tumor margin presents a significant challenge. Radiation oncologists must carefully determine the tumor bed when planning radiation therapy.Publications for analysis were searched in the PubMed and eLibrary databases using the relevant keywords.Titanium surgical clips are commonly used to localize the tumor cavity in mammary gland radical surgery. However, tissue movement and postoperative seroma formation can compromise the positioning of clips within the cavity, especially with abnormal fluid accumulation. Originally designed for hemostasis, these clips may create ambiguity when used to mark tumor bed margins. Various alternative methods for more precise delineation of tumor bed margins have advantages and limitations regarding practicality, patient comfort, and precision. Despite certain challenges in clinical application, gold markers remain the most efficient way of localizing primary tumors and resection margins.These findings highlight the urgent need for innovative approaches to marking the tumor cavity in mammary gland surgery to improve the precision of tissue localization for radiation therapy. Future advancements in this area should build on the advantages of gold markers and ensure accurate tumor localization.